Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: J Control Release. 2020 May 7;324:146–155. doi: 10.1016/j.jconrel.2020.05.003

Table 2:

Median survival of all groups. ISFI + C-TUS showed an increase in median survival compared to all other groups.

Treatment Group Median Survival (days)
ISFI + HT 13
HT 18
ISFI + M-TUS 23
C-TUS 25
Blank ISFI + C-TUS 26
ISFI 34
ISFI + C-TUS 51